Low on Antibodies, Blood Cancer Patients Can Fight off COVID-19 with T Cells
Perelman School of Medicine at the University of PennsylvaniaAntibodies aren’t the only immune cells needed to fight off COVID-19 — T cells are equally important and can step up to do the job when antibodies are depleted, suggests a new Penn Medicine study of blood cancer patients with COVID-19 published in Nature Medicine.